MedPath

Evaluation of PDL laser for the treatment of cutaneous leishmaniasis

Phase 2
Conditions
Cutaneous leishmaniasis.
Cutaneous leishmaniasis
Registration Number
IRCT2014072018536N1
Lead Sponsor
Dr Radmanesh clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
38
Inclusion Criteria

Age between 5-55 years; having at least 2 leishmania lesion on the everywhere of body skin with positive direct smear for leishman body.
Exclusion criteria: Pregnancy; lactation; using any other treatments before the beginning of the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Induration index. Timepoint: Before the begionning of the study, Every 2 weeks for 10 weeks. Method of measurement: Physical examination by dermatologist.
Secondary Outcome Measures
NameTimeMethod
Post inflammatory hyperpigmantation. Timepoint: Every 2 weeks for 10 weeks. Method of measurement: Physical examination by dermatologist.
© Copyright 2025. All Rights Reserved by MedPath